June 24, 2021
BY EMAIL
The Honourable Minister, Patty Hajdu Minister of Health Government of Canada
Email address: Patty.Hajdu@parl.gc.ca
Email address: hcminister.ministresc@canada.ca
Dear Honourable Minister,
Re: section 56 exemption applications supported by TheraPsil
I have been retained by TheraPsil to address the applications and application process under section 56 of the Controlled Drugs and Substances Act S.C. 1996, c.19 (“CDSA”). Section 56 exemption applications supported by TheraPsil have been delayed causing harm to patients. Further, the s. 56 application process is flawed which is causing harm to patients. I have been directed to start bringing court proceedings which will include mandamus applications and, soon after, an application challenging the constitutionality of the CDSA (probably also the Food and Drugs Act R.S.C., 1985, c. F-27 and Food and Drug Regulations C.R.C., c. 870 (“FDRs”)) if the s. 56 exemption applications supported by TheraPsil are not granted within 14 days and the government does not move towards reasonable regulations.
